Next Article in Journal
Towards a Rational Design of a Continuous-Flow Method for the Acetalization of Crude Glycerol: Scope and Limitations of Commercial Amberlyst 36 and AlF3·3H2O as Model Catalysts
Next Article in Special Issue
Significant Improvement of Metabolic Characteristics and Bioactivities of Clopidogrel and Analogs by Selective Deuteration
Previous Article in Journal
De Novo Sequencing and Transcriptome Analysis of Pleurotus eryngii subsp. tuoliensis (Bailinggu) Mycelia in Response to Cold Stimulation
Previous Article in Special Issue
Identification of New Epididymal Luminal Fluid Proteins Involved in Sperm Maturation in Infertile Rats Treated by Dutasteride Using iTRAQ
Communication

Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells

1
Department of Pharmaceutical Technology, University of Szeged, Eötvös u. 6, Szeged H-6720, Hungary
2
Goodwill Pharma Ltd., Cserzy Mihály u. 32, Szeged H-6724, Hungary
3
Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, Temesvári körút 62, Szeged H-6726, Hungary
*
Author to whom correspondence should be addressed.
Academic Editors: Shufeng Zhou and Wei-Zhu Zhong
Received: 4 March 2016 / Revised: 6 May 2016 / Accepted: 16 May 2016 / Published: 18 May 2016
(This article belongs to the Special Issue Drug Design and Discovery: Principles and Applications)
The nasal route receives a great deal of attention as a non-invasive method for the systemic administration of drugs. For nasal delivery, specific formulations containing excipients are used. Because of the sensitive respiratory mucosa, not only the active ingredients, but also additives need to be tested in appropriate models for toxicity. The aim of the study was to measure the cytotoxicity of six pharmaceutical excipients, which could help to reach larger residence time, better permeability, and increased solubility dissolution rate. The following excipients were investigated on RPMI 2650 human nasal septum tumor epithelial cells: β-d-mannitol, sodium hyaluronate, α and β-cyclodextrin, polyvinyl alcohol and methylcellulose. 3-(4,5-dimethyltiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) dye conversion assay and real-time impedance analysis were used to investigate cytotoxicity. No excipient showed toxicity at 0.3% (w/v) concentration or below while 1% concentration a significantly reduced metabolic activity was measured by MTT assay for methylcellulose and cyclodextrins. Using impedance measurements, only β-cyclodextrin (1%) was toxic to cells. Mannitol at 1% concentration had a barrier opening effect on epithelial cells, but caused no cellular damage. Based on the results, all additives at 0.3%, sodium hyaluronate and polyvinyl alcohol at 1% concentrations can be safely used for nasal formulations. View Full-Text
Keywords: nasal; cytotoxicity; nasal formulation; MTT dye assay; real-time impedance analysis nasal; cytotoxicity; nasal formulation; MTT dye assay; real-time impedance analysis
Show Figures

Graphical abstract

MDPI and ACS Style

Horváth, T.; Bartos, C.; Bocsik, A.; Kiss, L.; Veszelka, S.; Deli, M.A.; Újhelyi, G.; Szabó-Révész, P.; Ambrus, R. Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells. Molecules 2016, 21, 658. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules21050658

AMA Style

Horváth T, Bartos C, Bocsik A, Kiss L, Veszelka S, Deli MA, Újhelyi G, Szabó-Révész P, Ambrus R. Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells. Molecules. 2016; 21(5):658. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules21050658

Chicago/Turabian Style

Horváth, Tamás, Csilla Bartos, Alexandra Bocsik, Lóránd Kiss, Szilvia Veszelka, Mária A. Deli, Gabriella Újhelyi, Piroska Szabó-Révész, and Rita Ambrus. 2016. "Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells" Molecules 21, no. 5: 658. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules21050658

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop